Company Filing History:
Years Active: 2015
Title: Qingming Guo: Innovator in Quinazoline-7-Ether Compounds
Introduction
Qingming Guo is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on quinazoline-7-ether compounds.
Latest Patents
Qingming Guo holds a patent for quinazoline-7-ether compounds and methods of use. This invention provides quinazoline-7-ether derivatives, specifically 4-anilinyl-6-butenamido-quinazoline-7-ether derivatives, which act as inhibitors of receptor protein tyrosine kinases (RTK). These compounds are particularly useful in treating diseases and disorders where RTK activity is implicated, such as hyperproliferative diseases like cancer. The patent also includes methods for preparing these quinazoline derivatives and their use as therapeutic agents, either alone or in combination with other drugs.
Career Highlights
Qingming Guo is currently associated with Newgen Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against diseases that involve RTK activity.
Collaborations
Some of his notable coworkers include Wang Shen and Wei Xiao, who contribute to the collaborative efforts at Newgen Therapeutics, Inc.
Conclusion
Qingming Guo's innovative work in the development of quinazoline-7-ether compounds showcases his commitment to advancing medical science and improving therapeutic options for patients. His contributions are significant in the realm of cancer treatment and beyond.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.